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Oocytes are the precursor cells to the female gamete, or egg. While reproduction may 
vary from species to species, within humans and most domesticated animals, the oocyte 
maturation process is fairly similar. As an oocyte matures, there are various processes that take 
place, all of which have an effect on the viability of the individual oocyte. Barring outside 
damage that may come to the oocyte, one of the primary reasons for non-viability is that of 
abnormal gene expression. Within this project, we focus on two oocyte maturation techniques: in 
vivo (IVV) derived oocytes (our gold-standard) and in vitro matured (IVM) oocytes. A great 
disparity exists between the viability rates of the two origination techniques, and this disparity 
has led to low yields and inefficiency in the fields of cloning, fertility treatments, and 
personalized medicine.  
Within our project we use existing swine oocyte gene expression profile data as a proxy 
measure of viability, based on the similarity to IVV oocytes. Four statistical techniques for 
assessing the individual oocyte viability are proposed and compared, including: a weighted root 
mean squared deviation (wRMSD) approach, a distance kernel p-value approach, a distance 
tolerance interval approach, and a classification tree method. The relative performance of these 
four measures is discussed.  
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Oocytes are the precursor cells to what we often think of as the female egg cell. They 
operate and grow in essentially the same way within swine as they do in humans (Thomas, 
2016). Currently, there are numerous methods of deriving (growing) oocytes, each with its 
benefits. In vivo (IVV) derived oocytes are held as the gold standard for viability, and other 
known origination methods are sub-par by comparison. However, alternatively derived oocytes 
do have many traits that are desirable. The in vitro maturation (IVM) method is one such method 
of oocyte derivation, as it allows the researchers to have access to the oocyte from early on. 
There are however, many problems associated with this method. From past studies, it is shown 
that the viability rate associated with IVV derived oocytes is upwards of 95%, however for IVM 
oocytes (and other similar methods) the viability rate is roughly only 25% (Dr.	S.	Clay	Isom,	
personal	communication). Similar low viability concerns arise with the SCNT (somatic cell 
nuclear transfer, or traditional cloning) origination method.  With such a low viability rate it is 
only natural to try to alleviate the frustration and waste that comes from focusing time, resources 
and energy on oocytes that are simply not viable. But how can one know if an oocyte is viable 
prior to investing in it? In general, one cannot. However, methods can be developed that test 
individual oocytes for viability, establishing a viability-optimized general gene expression 
profile. As laboratory originated oocytes can be treated with a wash that promotes growth and 
expression patterns in chosen directions (Dr.	S.	Clay	Isom,	personal	communication), it is 
apparent that establishing methods to test individual oocyte viability and thereby derive a general 
viable profile for oocytes would, in theory, increase the viability of non-IVV oocytes. But rather 
than stopping there, one could test not only if specific genes were differentially expressed 
between the different groups, but also if one could use gene expression profiles to turn viability 
into a classification problem. 
Kwon et al. (2015) took embryos that were obtained from three different origination 
methods (IVV, IVM, and SCNT) and examined the gene expression profiles for 15 different 
genes of interest. In their project, a Weighted Root Mean Squared Deviation (wRMSD) was 
calculated based on expression level deviation from the mean expression level of the origination 
group. The average wRMSD for each origination group was calculated and compared. They 
found that the difference between the IVV group and the SCNT group was greater than the 
difference between the IVV group and the IVM group. These conclusions were relevant for 
comparing methods of origination, however we desire to compare individual oocyte viability.  
Within our project, the goal has been to establish origin-independent methods of 
evaluating individual oocyte viability, based simply on the observed gene expression profiles. As 
the process of collecting the observed gene expression profiles of oocytes is destructive, making 
the oocytes non-viable (and thereby making it impossible to tell if the oocyte would have been 
viable or not, simply by observing), there are a number of assumptions that one must make. First, 
assume that IVV-derived oocytes are the “gold standard” for oocyte viability. This assumption 
does not seem to be erroneous, as historically over 95% of all IVV-derived oocytes have been 
observed to be viable (Dr.	S.	Clay	Isom,	personal	communication). The second assumption that 
is made is that the closer an oocyte’s gene expression profile gets to the mean of the IVV gene 
expression profiles, the more likely the oocyte is to be viable. Third, assume that the IVV oocyte 




gene expression profiles are a representative sample of all IVV oocyte gene expression profiles, 
and likewise for the IVM oocytes within the data.  
Dr. S. Clay Isom provided the project dataset, which contained the gene expression 
profiles for 29 IVV derived oocytes as well as 29 IVM derived oocytes. Each of the gene 
expression profiles was represented in the form of a log2 fold-change on 67 genes of interest 
compared to a common “housekeeping” gene. These specific 67 genes were selected, as they are 
affiliated with early cell growth, regulation and viability (Dr.	S.	Clay	Isom,	personal	
communication). Overall there were few values that were missing (about 4.4%), but 
computationally if the case arose that a value was missing, that value was omitted from gene 
level calculations in the following methods.  
In this paper (from Bishop 2017), an adaption (on the single oocyte level) of the Kwon et 
al. (2015) wRMSD method is summarized in Section 2, along with three other novel methods – a 
Distance Kernel P-value method in Section 3, a Tolerance Interval method in Section 4, and a 
Decision Tree method in Section 5. Each of these methods is then compared for accuracy via 
simulation in Sections 6 and 7, and the methods’ performance is discussed in Section 8.  
 
2. WEIGHTED ROOT MEAN SQUARED DEVIATION KERNEL DENSITY P-VALUE 
 
We use an application of the weighted root mean squared deviation (wRMSD) approach 
proposed by Kwon et al (2015). Here, we compute the wRMSD from the center of the oocyte 
viability class. In the more practical case that viability status is unknown, we would then 
compute the wRMSD from the center of the oocyte maturation class (center of IVV if using an 
IVV oocyte, or IVM if using an IVM oocyte). Again, we operate under the assumption that IVV 
is considered viable. Kwon et al. (2015) said “We considered each gene expression to be an 
independent event; therefore, we combined all of the expression measurements of each (gene) 
sample in the calculation of the wRMSD. To minimize the bias from a measurement error of a 
gene expression profile with a low coefficient of variation (CV), the deviation of each gene 
expression level from the mean was weighted with the CV of the gene in the group.” Within the 
wRMSD calculation there are three main parts: the reference expression level (mean expression 
level for the gene within group), the expression level of the specified gene within the oocyte of 
interest, and the weighting coefficient. The weighting coefficient was further made up of “the 
proportion of the CV for the expression level of the ith gene to the sum of CV for those of all 
genes in the group” (Kwon et al., 2015):  
 
                  (1) 
In Equation 1, wRMSD is defined for a given oocyte.  Here, Ei refers to the expression 
level of the ith gene in the oocyte, Emi refers to the reference expression level for the oocyte (i.e. 
mean of the IVV if the oocyte is IVV or IVM if the oocyte is in the IVM group) of the ith gene, 
and wi refers to the weighting coefficient.  
We set up the null hypothesis that an observed oocyte (with an accompanying wRMSD) 













Figure 1. The wRMSD distribution of IVV and IVM oocytes with calculated kernel 
density for the IVV wRMSD distribution overlaid on both histograms. 
 
values for likelihood of belonging to the “viable” class were then computed for the individual 
oocytes by comparing the oocyte’s observed wRMSD to the kernel density of the viable (or 
IVV) wRMSD distribution, and computing an upper tail area (see Figure 1). These p-values were 
then compared to an alpha 0.05 level for determining if there was enough evidence to reject our 
null hypothesis (that the observed oocyte was viable). This Kernel Density p-value portion was 
not utilized in the Kwon et al. paper, however it is a reasonable and necessary application of 
their published method that allows for individual oocyte classification and comparison between 
results from this and other methods.  
In Figure 1, an example IVM oocyte has been selected and its wRMSD has been found to 
be 1.19. The wRMSD of the oocyte is then compared to the kernel density of the wRMSD for the 
IVV group; we can then set up a hypothesis test with a null hypothesis that the observed oocyte 
comes from the IVV group. By computing an upper tail area from the kernel density, we can 
observe a p-value for our example oocyte equal to 0.052. This p-value is larger than our 0.05 
cutoff, so we would classify the observed oocyte as viable (by our assumption that the more 
closely related to the IVV group that an oocyte is, the more likely it is to be viable). 
 
3. DISTANCE KERNEL DENSITY P-VALUE METHOD 
 
We considered also a distance measurement method as a modification to the wRMSD 
approach presented by Kwon et al. (2015). It utilizes only a subset of the available genes; those 
that a limma eBayes approach (Ritchie, 2015) has determined are differentially expressed 
(between IVV and IVM groups) at an alpha 0.05 level. Briefly, the limma eBayes approach  





Figure 2. The distance distribution of IVV and IVM oocytes with calculated kernel 
density for the IVV distance distribution overlaid on both histograms.  
 
performs a modified t-test on the expression level of each gene, testing for differential expression 
between two conditions (IVV and IVM here). The gene expression profile of all IVV (or viable) 
oocytes is computed, and the mean expression is taken for each gene in order to form an IVV 
group mean gene expression profile. Using only the subset of differentially expressed genes, the 
distance measure for each oocyte from the mean of the IVV group gene expression profile is then 
computed. Here, distance is measured as an adaption to the Kwon et al. wRMSD approach, with 
weighting coefficients based on the variance of the genes:  
 
      (2) 
 
In Equation 2, we only use information from differentially expressed genes. Emi 
represents the mean of the IVV (or viable) group for gene i. Ei represents the expression level of 
the ith differentially expressed gene for the specified oocyte. Wi is the weight for the specified 
gene i,  
The distance kernel density is then calculated for the IVV (or viable) oocytes, based upon 
the calculated IVV distances. We then can use this kernel density distribution (see Figure 2) to 
set up a hypothesis test for each of the individual oocytes, using the following null and 
alternative hypotheses: H0 – The oocyte distance comes from the IVV (viable) distribution of 














IVV (viable) class, vs. Ha – The oocyte distance does not come from the IVV (viable) 
distribution of distances, i.e. the observed distance for the oocyte is outside the expected range if 
it is of the IVV (viable) class. In order to make a decision for the hypothesis test, we compute the 
upper tail probability above the distance observed in the oocyte of interest. This upper tail area is 
our observed p-value. 
In Figure 2, the same example IVM oocyte has been selected as in Figure 1, and its 
calculated distance has been found to be 9.78. The distance of the oocyte is then compared to the 
kernel density of the distances for the IVV group; we can then set up a hypothesis test with a null 
hypothesis that the observed oocyte comes from the IVV group. By computing an upper tail area 
from the kernel density, we can observe a p-value for our example oocyte equal to 0.019. This p-
value is smaller than our 0.05 cutoff, so we would classify the observed oocyte as non-viable (by 
our assumption that the more closely related to the IVV group that an oocyte is, the more likely it 
is to be viable). 
 
4. TOLERANCE INTERVAL METHOD 
 
A tolerance interval is a numerical interval that is calculated to provide limits wherein at 
least a specified proportion of a sampled population falls with an indicated level of confidence. 
Oftentimes, tolerance intervals are constructed and applied in areas such as quality control or 
manufacturing to establish that certain product standards are being met by the overall bulk of the 
products. “More specifically, a 100×p%/100×(1−α) tolerance interval provides limits within 
which at least a certain proportion (p) of the population falls with a given level of confidence 
(1−α)” (Young, 2010). Tolerance intervals are based on the sampled data; however they allow us 
to say something about the population distribution. “A tolerance interval differs from a 
confidence interval in that the former encloses a proportion of the entire population distribution, 
while the latter is constructed to contain the value of a population parameter” (Millsap, 1988). 
Frequently, tolerance intervals are based on a specified distribution of the data, and more often 
than not, that distribution is assumed to be normal. However, we can also make the tolerance 
interval more general by taking a non-parametric approach (Wilks, 1941). In Wilks’ paper, he 
proves that there is a systematic way of calculating a confidence interval for an unknown data 
distribution; a tolerance interval can be calculated for a given population coverage proportion, 
level of confidence and minimum sample size, that guarantees at least the given population 
coverage proportion. This approach is outlined as follows: 
• Let a be the average value which p is to have, where p is the proportion of the population 
to be included in the interval (the mean coverage).  
• Draw a sample of size n from the population subject to the constraint that 
[(1-a)(n +1)]/2 = r, a positive integer. 
• Order the sampled data according to increasing magnitude from x1 to xn. 
• Let L1 = xn-r+1, the upper tolerance limit of our 1-sided non-parametric tolerance interval. 
As noted above, we need a minimum sample size value to ensure proper coverage of the 
population with the specified level of confidence. Within the framework of this project, we 
utilized the principles of this method to create a 95% non-parametric one-sided tolerance interval 
for 95% coverage of the IVV distance distribution. The distribution of distances for the IVV  





Figure 3. The distribution of IVV distances. The kernel density was overlaid to help 
depict the skewedness of the distribution. 
 
oocytes is right skewed (see Figure 3), so we used an application of the non-parametric tolerance 
interval method.  
For a non-parametric approach, the calculation of the tolerance interval can be different 
than when we specify a distribution for the data. As we do not restrict our interval to a specific 
distribution, we require a larger sample size in order to maintain the same level of confidence 
and coverage for our tolerance interval than that of a specified distribution (i.e. Gaussian, 
Weibull, etc). The calculations for the minimum required sample size of a non-parametric 





The above equation is an approximation for the minimum sample size n, needed for a 
non-parametric tolerance interval with confidence level γ, and population coverage proportion 
p. We also note that we are calling a specified value from a chi-squared distribution with 4 
degrees of freedom. 
For our project, the minimum required sample size for a 95% confidence and at least 95% 
coverage was n=94, so we ended up needing a sample size of 100.  In the simulations of Section 
6 below, we use n=100 oocytes, and we proceed with the construction of the tolerance interval 
here solely for demonstration purposes (though the actual sample size in the project dataset is 
n=58, so the actual coverage in this demonstration example is likely less than 95%). For each 















Figure 4. The distance distribution of IVV. The upper limit of the 95% confidence, 95% 
coverage non-parametric tolerance interval for the IVV group was calculated to be 9.63.  
 
function as previously given in Equation 2. Those oocytes that individually have a distance 
statistic outside of the constructed tolerance interval for the IVV oocytes (i.e. their distance was 
greater than that of the upper tolerance bound) were selected as being nonviable (see Figure 4). 
In Figure 4, the same example IVM oocyte as in Figures 1 and 2 is shown with distance 
calculated as 9.78. As the observed distance of 9.78 is larger than the upper tolerance limit of 
9.63, we would classify this oocyte as non-viable.   
 
5. CLASSIFICATION TREE METHOD	
 
Classification trees or decision trees are a graphical representation of a set of rules used to 
classify data into categories. They are appropriate to use when one has a 2 or more level 
categorical variable as an outcome, with one or more variables as predictors. In general, we 
would use a classification tree to predict the class or outcome level of a number of observations 
within a dataset, based on the observed values of the predictor variables. In R, the default index 
for choosing the best split in the data (for classification) is the Gini index. The Gini index is a 
measure of impurity of a node (or a whole tree). The Gini impurity measure can be calculated in 













Within the Gini calculation, we are trying to classify items into m classes using a set of 
training items E. Let pi (i= 1,…,m) be the fraction of the items of E that belong to class i. Thus, 
the Gini index reaches an optimal value of zero when the set E contains items from only one 
class. Construction of a decision tree using this index can be broken down into a number of 
simple steps: 
1. The tree algorithm uses a training data set to build the tree, in other words, one needs to 
know the true outcomes in order to build a classification tree that can be used on other 
datasets drawn from the same population.  
2. The algorithm then uses the predictor variables to make the most optimal splits in the 
data. An optimal split is defined as using a variable to split the data from one group into 
two that provides the greatest differentiation between the different classes, separating 
them from one another as well as possible.  
3. The algorithm uses the most important variables to make splits in the data. If the 
observations in a specified branch of the tree contain a diverse group of classes, then the 
algorithm finds “the best” rule based on a single variable/feature to split that branch into 
two smaller branches. The quality of the split is again measured based upon a reduction 
in the Gini impurity measure. 
4. Only if every observation in the “branch” of the tree is from the same class, does the tree 
form a terminal node or leaf. 
5. One can invoke the minsplit argument in the rpart function of the package rpart 
(Therneau, 2015) for R (R Core Team, 2016) to indicate the minimum number of 
observations needed to make a split in the data (to mitigate overfitting and nodes with 
single observations). 
This process of actually using a tree to classify objects was aptly summarized in the following 
way: “In order to classify an object, we start at the root of the tree, evaluate the test, and take the 
branch appropriate to the outcome. The process continues until a leaf is encountered, at which 
time the object is asserted to belong to the class named by the leaf” (Quinlan, 1986). 
Within the framework of this project, the outcome or class variable is oocyte viability. A 
key advantage to a classification tree is that it provides a visual rule for distinguishing between 
viable and non-viable classifications, based again on the most differentially expressed genes (as 
was the case with our previous methods using the limma eBayes method). Again, the genes are 
the variables on which the tree is split, and while all genes have a chance of being chosen 
initially, the tree will chose the genes to split on that give the best split as calculated by the Gini 
Index (see Figure 5). Using the same example IVM oocyte as in Figures 1, 2 and 4, we arrive at a 
classification of non-viable (shown in the red boxed terminal node of Figure 5). 
As single trees can have a tendency to over-fit the data, often they are trimmed back 
slightly such that the last few splits are not used. In order to remedy any possible problems of 
overfitting, we fit a single tree to the data, and then used a cp cutoff value of 0.18, which yielded 
the smallest possible tree within one standard error of the optimal tree size for that specific 
dataset. This cutoff value was used with all trees in the simulations of Section 6.  
 
  





Figure 5. A classification tree that was grown for the dataset; the splits are conducted 
based upon the gene expression values of the oocytes in the dataset. The resulting 




In order to adequately compare the four previously summarized methods from Sections 2 
through 5, simulations were conducted, in which datasets were generated and results were 
gathered for the four methods. As the goal was to determine how the methods compared to one 
another, the simulation was constructed as a function in R, with the following five variables that 
could be altered to yield different situations for the simulated data:  
• n, the number of oocytes to be simulated 
• Pi, the mixing proportion for the mixture distribution of the IVM oocytes (i.e. the degree 
of similarity between the viable IVM group and the IVV group) 
• δ, the magnitude of differential expression for genes that are differentially expressed 
between IVM and IVV groups 
• WhichGenes, a given list of genes to be differentially expressed in the simulation 
• ProbViableIVM, the prior probability that any given IVM oocyte is viable  
 
At the start of a simulation, the function starts with the first of the n oocytes (for our 
project, n=100), and decides whether it will be generated as an IVV or IVM oocyte. This process 
is done randomly using a binomial generator with probability of IVV equal to 0.5. After 




maturation type is decided, we determine if the oocyte will be simulated as a viable oocyte or 
not. For the sake of the simulation, all IVV oocytes were given the viable class, while the 
probability that an IVM oocyte is deemed viable depends on the simulation variable 
“ProbViableIVM” (binomial distribution with probability of viable being equal to 
“ProbViableIVM”). After each of the oocytes has been assigned a maturation and viability type, 
the individual gene expression profiles for each oocyte are generated.  
Within the process of gene expression profile generation, the simulation function takes 
into account specific genes that the user wants to make sure are differentially expressed between 
viable and non-viable classes. The list of these gene names is to be supplied to the function by 
the user in the simulation argument “WhichGenes” (for our project, these were derived from the 
Isom data). For the genes identified as being differentially expressed, we then determine the 
degree of differential expression. Each named gene has its individual degree of differential 
expression, δi, which is generated randomly from a uniform distribution, with minimum equal to 
the user supplied variable δmin, and maximum equal to the user supplied variable δmax (in our 
case, these are calculated as the minimum and maximum respectively of the absolute value of the 
log fold-change for the differentially expressed genes from the Isom data). If the gene of interest 
is not included in the list of genes to be differentially expressed, δi is simply set to zero. Next, for 











The expression value for gene i of the oocyte is simply a random value from a standard 
normal distribution if the oocyte is an IVV oocyte. If the oocyte is a non-viable IVM oocyte, 
then the expression value for gene i is a random value from a normal distribution with mean 
equal to δi and standard deviation equal to one. If the oocyte is a viable IVM oocyte, then the 
expression level for gene i is a mixture of the two aforementioned distributions, with the mixing 
proportion, Pi, determining the degree of the mixture (i.e. the probability it will be more similar 
to the IVV group, see Figure 6). 
For the purpose of this project, we have chosen only to vary the variables Pi and 
ProbViableIVM using the values 0.1, 0.3, 0.5, 0.7 and 0.9; all other variables remained constant 
throughout the simulations. Constant values and the list of differentially expressed genes came 
from the provided Isom data. We simply wished to see the effects of our mixing proportion as 
well as the probability of viable IVM oocytes, and how they affected our methods. Note, as we 
increase the mixing proportion, we are simply increasing the similarity between viable IVV and  
V iable IV M Expression for Gene i =   ⇤X + (1   ) ⇤ Y,
NonV iable IV M Expression for Gene i = Y ⇠ N( i, 1),
  ⇠ Binom(1, P i).












Figure 6. Example expression value distributions for IVV and Non-Viable IVM oocytes for 
gene i, such that δi=3 (for example purposes). The distribution of the Viable IVM oocyte 
expression value is represented as a mixture of the two above distributions, with mixing 
proportion Pi. 
 
viable IVM oocytes within the simulation. When we increase the probability of viable IVMs, 
what we are doing is increasing the probability that a viable IVM oocyte is generated within our 
simulation set, as our oocyte number stayed constant across simulations. We note that this 
creates an imbalance in the group sizes, which we can then use to test how our methods handle 
such conditions. The support and resources from the Center for High Performance Computing at 
the University of Utah are gratefully acknowledged in providing the means of running the 
simulations (for a helpful tutorial, see Barton 2016). As the University of Utah system is set up 
for cluster computing, we were able to run 500 iterations at each simulation level in under 14 
hours whereas it would have taken multiple days to compute the same amount on a traditional 
PC. 
In addition to gene expression data generation, the functions created for the simulations 
also compile results from our primary measures of interest for model evaluation, as averaged 
over 500 simulations: proportion correctly classified (PCC), sensitivity and specificity for each 
of the models. In this context, we define proportion correctly classified as the count of those 
oocytes that were classified as either being viable or non-viable when it was truly their respective 
viability status, divided by the total number of oocytes that were classified within the simulation 
(in this case 100). This was repeated 500 times and then averaged across each simulation level 
combination. A similar process was done for sensitivity and specificity. Sensitivity was defined 
as the count of correctly classified viable oocytes divided by the total number of viable oocytes, 
and specificity was defined as the count of correctly classified non-viable oocytes divided by the 
total number of non-viable oocytes. 





Figure 7. The Proportion Correctly Classified (PCC) of the different simulation combinations, 
as it specifically relates to the Mixing Proportion (Pi). The different line types, as well as the 
increasing depth of the blue color signify probability of a given IVM being viable across the 




On examining Figure 7, we notice that the tolerance method approach tends to outclass 
the other methods when looking at the proportion correctly classified (PCC).  A similar result is 
seen in Figure 8 when sensitivity (proportion of viable oocytes correctly classified) is used as our 
measured outcome. In both outcomes, the tolerance interval approach scores roughly two to three 
percentage points higher on average (after averaging across 500 simulations at each mixing 
proportion by probability viable IVM combination) than the relatable wRMSD and distance 
kernel methods. In the aforementioned areas, the disparity between tolerance intervals and that of 
a classification tree depend on the variable ProbIVMViable, as the classification tree method 
doesn’t follow the same exact patterns of results as the other three methods.  
Also, in reviewing Figure 7, we note that it appears that the variable Pi (mixing 
proportion) seems to have very little effect on the method outcomes. We do see some changes in 
the slopes of the lines within the classification tree method in Figure 7 and Figure 8; for the other 
three methods it seems to be of little importance. The reason as to why the variable Pi has such 
little difference in the overall results, is that in the design of the simulation (see Section 6), the  
 





Figure 8.  The Sensitivity, or ability to correctly classify the viable oocytes of the different 
simulation combinations, as it specifically relates to the mixing proportion Pi. The different 
line types, as well as the increasing depth of the blue color signify the probability of a given 
IVM oocyte being viable across the four different methods. 
 
portion of the data that is changed as Pi is varied is merely a “fraction of a fraction” of the 
overall data generated in the dataset, as such it generally has little overall effect.  
While it appears that the classification tree is generally outclassed by the other three 
methods (specifically tolerance intervals) in sensitivity, it does outperform all other methods 
when looking at specificity (the ability of the methods to correctly classify non-viable oocytes, 
see Figure 9). In Figure 9, it appears that as the probability of an IVM oocyte being viable 
increases, the harder time the decision tree has at correctly classifying the non-viable samples.  
 
8. DISCUSSION  
 
Currently in the fields of cloning and embryology, researchers constantly run into 
complications and unplanned procedural failures due to the effects of low viability amongst 
oocytes derived in a laboratory setting. Non-viability of samples is a costly and unwanted 
outcome that is worth evaluating and attempting to mitigate. Past focus has been on evaluating 
origination methods and determining their ‘closeness’ to one another; specifically, the method’s  





Figure 9.  The Specificity, or ability to correctly classify the non-viable oocytes of the different 
simulation combinations, as it specifically relates to the mixing proportion Pi. The different 
line types, as well as the increasing depth of the blue color signify the probability of a given 
IVM oocyte being viable across the four different methods. 
 
proximity to IVV derived oocytes, the gold standard (Kwon et al. 2015). While this may be a 
decent approach at evaluating origination methods, we claim that we can use alternate 
approaches to evaluate, and thereby later improve the quality of, individual oocytes within a 
given method. With recent advances in gene expression technology, nutrient washes can be 
created in order to encourage the oocytes to express specific genes within a given origination 
method, thereby improving the viability and quality of the samples, while still retaining the 
flexibility of using the origination method of choice. 
While the goal was to identify methods that were best to use overall, we notice that we 
actually have a few different situations represented in the data, and as a result we get different 
“top methods” depending on the situation at hand. As noted above in Figures 7 and 8, when 
looking at PCC and sensitivity, tolerance intervals seemed to always be the method that 
performed the best, however the kernel density p-value approach wasn’t far behind, with our 
modification of the published Kwon wRMSD method following shortly behind that. However, 
one reason that these methods could be performing so well in these result measurements (PCC 
and sensitivity), is that there is an imbalance of sample sizes. The viable oocyte group is 
consistently larger than the non-viable group, simply due to the nature of the probabilities, as all 




IVV oocytes are simulated as being viable, while an increasing number of IVM oocytes are 
counted as viable as the variable ProbIVMViable starts to increase. So, as a reiteration, as the 
variable ProbIVMViable increases, the disparity between the viable and non-viable group sizes 
starts to increase (note, when ProbIVMViable is set to 0.90, nearly all oocytes are in the viable 
group). It appears as though the classification tree method is more balanced and more immune to 
the effects of this imbalance in the data, as it appears to perform roughly equally across all 
groups, though it does still get swayed some as ProbIVMViable reaches higher values (see 
Figures 7, 8, and 9). So, if one is interested in a method that is more robust to the effects of 
imbalanced samples, or has a vested interest in the accuracy of identifying the non-viable 
samples (where they severely outperformed the other methods, see Figure 9), classification trees 
may be the method to choose. If not, we would recommend the non-parametric tolerance interval 
approach based upon our calculated distance measure.  
At this point, we acknowledge the possible limitations of these simulations. First, we note 
that we have made a number of assumptions that we cannot fully prove with the resources at 
hand. First, we assume that oocytes that have gene expression profiles that are more like those of 
IVV oocytes are going to be more viable. Second, we assume the center of the observed IVV 
distribution to be the optimal gene expression profile. Third, we assume that the data provided to 
us from Dr. Isom is a representative sample of all IVV and IVM oocytes (viable and non-viable). 
Fourth, assumptions were made about the relative rates of viability in the different origination 
method groups based upon conversations with Dr. Isom, as he was our expert in the field. While 
these are a fair amount of assumptions, we did take precautions as to try to minimize their 
effects. The methods used were built or conceived in a way that they operate independent of 
oocyte origination method, they require no distributional assumptions of the oocyte data, and as 
demonstrated, do not require a complete balance of group sizes (though it may have yielded 
slightly different results had we forced this on the generated data).  
While overall the methods seemed to perform well in specific areas, there are some 
procedural aspects of these simulations that can be better handled. One such example is the 
techniques for handling missing values in the data. With oocyte data, when obtaining the gene 
expression profiles of the oocyte, we destroy the oocyte, thereby making it possible only to 
attempt to retrieve the profile once; if we miss a few values, we cannot go back and “re-observe” 
them. Hence, having a set method for handling missing values is advised. One recommendation 
could be to impute or borrow information from other similar oocytes in the same origination 
group. For the purposes of these simulations, if there was a missing value in the original Isom 
data, that value was simply omitted from the gene level calculations. Despite not being able to go 
back and “re-observe” the missing values, they were fairly infrequent (about 4.4% of the specific 
gene-level data) in the original dataset.  
Further method application and development is necessary in this field, as we showed how 
under the simulated circumstances that our three proposed methods consistently outperformed 
the previously published wRMSD method by Kwon et al. (2015); however, our proposed 
methods were quite rudimentary or basic. More advanced classifiers such as Random Forest, 
neural networks, and the like, may end up doing a better job on these types of classification 
problems. But, also bear in mind, if the dataset has a large number of variables (such as genes 
here), then these other methods, while more complex and possibly better classifiers, may require 
a large increase in processing power and computing time.  






To this point, viability of laboratory accessible oocytes has stood in the way of progress 
in numerous fields. We propose an alternate approach to the viability issue, by not only looking 
at individual genes as coding for viability, but by using gene expression profiles as a way to 
classify between possible viable and non-viable oocytes. We have proposed four methods: a 
wRMSD approach, a Distance Kernel Density approach, a Distance Tolerance Interval, and a 
Classification Tree. Of these approaches, the Distance Tolerance Interval approach was overall 
the most accurate, however the Classification Tree approach yielded results much quicker and 
was able to hold a higher specificity score (able to correctly classify the non-viable cases better). 
While the wRMSD and Distance Kernel Density approaches yielded high results, their percent 
correctly classified values were lower than the Distance Tolerance Interval approach, and they 
took more time to run, therefore they are not recommended for future use within this simulation 
setup. Future real data exploration and further simulation studies are suggested to see how these 
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